The growing trend of consuming 5meo dimethyltryptamine in this country presents considerable risks and complicated statutory problems. Currently, 5MeO copyright remains a Schedule I substance according to Canadian CDSA, rendering its website holding and distribution unlawful. While ingestion delivers the substance swiftly, it besides poses unique h